Advertisement

Ads Placeholder
Loading...

Brooks Laboratories Limited

BROOKS.BOBSE
Healthcare
Drug Manufacturers - Specialty & Generic
72.29
0.80(1.12%)
Indian Market opens in 61h 38m

Brooks Laboratories Limited (BROOKS.BO) Stock Overview

Explore Brooks Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio9.74
EPS (TTM)$7.35
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$77.16
3 Months$2.62
1 Year Target$138.91

BROOKS.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Brooks Laboratories Limited (BROOKS.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $138.91.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.74 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.14%
5-Day Change
28.61%
1-Month Change
21.62%
3-Month Change
-3.96%
6-Month Change
-45.25%
Year-to-Date (YTD) Change
-7.86%
1-Year Change
-42.01%
3-Year Change
5.02%
5-Year Change
-3.20%
All-Time (Max) Change
18.59%

Contact Information

91 22 6193 3100
201, The Summit Business Park, Mumbai, NaN, 400093

Company Facts

2,930 Employees
IPO DateSep 5, 2011
CountryIN
Actively Trading

Frequently Asked Questions